Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 3,912.00
+124.00 (3.27%)
Oct 30, 2026, 5:00 PM CET
Genmab Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of kr 3,988. The average 1-year stock price forecast is 1.94% higher than the current stock price, while the lowest is kr 2,850 (-27.15%) and the highest is kr 4,526 (+15.70%).
Price Target: kr 3,988 (+1.94%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 13 | 13 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 18 | 17 | 16 |
Financial Forecast
Revenue This Year
4.77B
from 3.72B
Increased by 28.31%
Revenue Next Year
5.74B
from 4.77B
Increased by 20.36%
EPS This Year
13.08
from 17.72
Decreased by -26.17%
EPS Next Year
19.15
from 13.08
Increased by 46.36%
EPS and Forward PE are based on non-GAAP adjusted numbers.